News

| Yoav Meer
December 19th, 2017

Gornitzky represents Shefa Yamim (A.T.M) Ltd. in its initial public offering on the London Stock Exchange.

Gornitzky represented Shefa Yamim (A.T.M) Ltd. in its initial public offering on the London Stock Exchange. Shefa Yamim is a multi-commodity gemstone mining exploration Company, with operations in Northern Israel.

 

Shefa Yamim (A.T.M) Ltd. was represented by Itay Geffen (Partner) and Associate Yoav Meer.

August 3rd, 2017

Gornitzky represents the underwriters, led by Cantor Fitzgerald, in Kamada's follow-on offering. 

Gornitzky represented the underwriters, led by Cantor Fitzgerald, in the USD 15 million follow-on offering of Kamada Ltd. on the NASDAQ Global Select Market. Kamada is a plasma-derived protein therapeutics company focused on orphan indications, and its shares are dually traded on the NASDAQ and the Tel Aviv Stock Exchange.

Cantor Fitzgerald acted as sole book-running manager for the offering. Raymond James, Oppenheimer & Co., Ladenburg Thalmann and Chardan acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner), Yoav Meer (Associate), Danielle Skald (Associate) and Sharon Strauss (Associate).

December 19th, 2016

Gornitzky represents Sabon Shel Pa’am and its Shareholders in the Sale by its shareholders of approximately 70% of the shareholding of Sabon to Yves Rocher Group

Gornitzky represented Sabon Shel Pa’am (“Sabon”) and its Shareholders in the sale by its shareholders of approximately 70% of the shareholding of Sabon to Yves Rocher Group. Sabon is a leading producer and retailer of cosmetic, body care, home style and ambience products sold in concept stores around the world. Yves Rocher is a worldwide cosmetics and beauty brand, based in La Gacilly, France. Yves Rocher is present in 88 countries on five continents

As part of the transaction, the selling shareholders will continue to hold a significant position in the global company and shall take an active role in the management of the company for the next several years, after which they shall have an exit right. In addition to negotiating the sale agreement, we were required to negotiate a shareholders agreement between Yves Rocher and the selling shareholders for the relationship between the parties and the management of the companies.

For further reading in the Marker (Hebrew)

Sabon Shel Pa’am (“Sabon”) and its Shareholders is represented by Chaim Friedland (partner), Yehonatan Raff, Yoav Meer, Sam Berkowitz, Danielle Skald (tax) and Bar Sarafian (labour)

November 11th, 2015

Gornitzky represented the underwriters, led by Piper Jaffray, in Vascular Biogenics Ltd.’s (operating as VBL Therapeutics) USD 15 million offering of shares and warrants on the NASDAQ Global Market. VBL Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer.

Gornitzky represented the underwriters, led by Piper Jaffray, in Vascular Biogenics Ltd.’s (operating as VBL Therapeutics) USD 15 million offering of shares and warrants on the NASDAQ Global Market. VBL Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer.

 

Piper Jaffray & Co. acted as sole bookrunner for the offering. JMP Securities acted as lead manager and Roth Capital Partners and LifeSci Capital acted as co-managers.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

 

April 1st, 2015

Gornitzky represented National Petroleum Ltd. in the sale of its shares in West Indies Oil Company Ltd. to the Government of Antigua and Barbuda.

Gornitzky represented National Petroleum Ltd., a Bermuda company, in the sale of its shares in West Indies Oil Company Ltd., an Antiguan energy company and a regional leader, to the Government of Antigua and Barbuda.

National Petroleum Ltd. was represented by Moriel Matalon (Managing Partner) and Yoav Meer.

February 4th, 2015

Gornitzky represented Le Peigne in its investment in Taboola, as part of a consortium of investors in Taboola’s USD 117 million financing round. 

Gornitzky represented Le Peigne in its investment in Taboola, as part of a consortium of investors in Taboola’s USD 117 million financing round. Le Peigne is controlled by the Arnault Group, which also controls Christian Dior and LVMH Moet-Hennessy—Louis Vitton.

Taboola is a leading content discovery and marketing platform, serving over 130 billion recommendations to over 350 million unique visitors every month.

Le Peigne was represented by Chaim Friedland (Partner) and Yoav Meer.

November 26th, 2014

Gornitzky represented Northland Capital Markets in the USD 10 million follow-on offering of On Track Innovations Ltd. (NASDAQ: OTIV) on the NASDAQ Global Market.

Gornitzky represented Northland Capital Markets in the USD 10 million follow-on offering of On Track Innovations Ltd. (NASDAQ: OTIV) on the NASDAQ Global Market.  Northland Securities acted as sole underwriter for the offering.

 

Northland Capital Markets, a boutique investment banking firm that focuses on growth companies and institutional investors, was represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

August 5th, 2014

Gornitzky & Co. represented the underwriters, led by Credit Suisse and Jefferies in Macrocure Ltd.’s USD 53.5 million initial public offering on the NASDAQ Global Market.

Gornitzky & Co. represented the underwriters, led by Credit Suisse and Jefferies in Macrocure Ltd.’s USD 53.5 million initial public offering on the NASDAQ Global Market.

Credit Suisse and Jefferies acted as joint book-running managers for the offering. Nomura Securities and Oppenheimer & Co. acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

March 26th, 2014

Gornitzky & Co. represented the underwriters, led by Credit Suisse, Jefferies and BMO Capital Markets, in MediWound Ltd.’s USD 80.5 million initial public offering on the NASDAQ Global Market.


Gornitzky & Co. represented the underwriters, led by Credit Suisse, Jefferies and BMO Capital Markets, in MediWound Ltd.’s USD 80.5 million initial public offering on the NASDAQ Global Market.

 

Credit Suisse, Jefferies and BMO Capital Markets acted as joint book-running managers for the offering. Oppenheimer & Co. acted as co-manager for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

January 16th, 2014

Gornitzky represented Shilav Group Ltd. in the sale of all of its shares in Tiny Love Ltd. and affiliated companies.

Gornitzky represented Shilav Group Ltd. in the sale of all of its shares in Tiny Love Ltd. and its U.S. and Chinese affiliates to Dorel Industries Inc. (TSX: DII/B), a Canadian corporation based in Quebec. Dorel Industries designs and manufactures for three areas: juvenile, home furnishings and recreational/leisure. The purchase price was not disclosed.

 

Tiny Love Ltd. is in the business of designing, developing and supplying retailers and distributors with activity gyms, mobiles, baby gear, baby toys and on-the-go baby toys.

 

Shilav Group Ltd. was represented by Chaim Friedland (Partner), Timor Belan (Partner), Avner Finkelshtein (Partner, Antitrust) and Yoav Meer.

June 5th, 2013

Gornitzky & Co. represented the underwriters led by Morgan Stanley and Jefferies in the USD 59 million initial public offering of Kamada Ltd. on NASDAQ.

Gornitzky & Co. represented the underwriters, led by Morgan Stanley and Jefferies, in the USD 59 million initial public offering of Kamada Ltd. on the NASDAQ Global Select Market.

 

Kamada, a biopharmaceutical company engaged in specialty life-saving therapeutics, was traded on the Tel Aviv Stock Exchange prior to the NASDAQ offering and its shares are now traded on both the TASE and NASDAQ.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

April 28th, 2013

Gornitzky represented Chinese conglomerate, Fosun International Ltd., in their acquisition of Alma Lasers Ltd. for approximately USD 240 million.

Gornitzky represented Chinese conglomerate, Fosun International Ltd. (HK: 656), in all legal aspects of their approximately USD 240 million acquisition of a 95.6% stake in Alma Lasers Ltd., a manufacturer of lasers used in cosmetic surgery. Alma Lasers was purchased by Fosun International's subsidiaries, Shanghai Fosun Pharmaceuticals (Group) Co. Ltd. and Chindex Medical Ltd., and its private equity fund, Pramerica-Fosun China Opportunity Fund.

 

Fosun International is the largest private-owned (non-governmental) conglomerate in Mainland China. This is Fosun International's first acquisition since its public offering on the Hong Kong Stock Exchange and its first ever investment outside of China.

 

Fosun International Ltd. was represented by Chaim Friedland (Partner, Corporate), Gil Grady (Partner, Tax), Dubi Gross (Partner, Corporate), Avner Finkelshtein (Antitrust), Gilad Lubinsky (Litigation), Michael Ayalon (Labor), Mirit Ber-Hoffman, Yehonatan Raff, Joanna Yanowsky and Yoav Meer.

January 15th, 2013

Gornitzky & Co. represented Mustang Mezzanine Fund in connection with a mezzanine loan to Malka Retail Group Ltd., a privately-held company and a dominant middle-size fashion manufacturer and retailer, with leading brands such as “ML” and “Jump”.

Gornitzky & Co. represented Mustang Mezzanine Fund in connection with a mezzanine loan to Malka Retail Group Ltd., a privately-held company, and a dominant middle-size fashion manufacturer and retailer, with leading brands such as “ML” and “Jump”. The transaction with Mustang is directed towards funding the future non-organic growth of the group.

 

Mustang Mezzanine Fund was represented by Mr. Chaim Friedland (Partner), Mr. Yair Shiloni (Partner), Mr. Yiftah Farber and Mr. Yoav Meer.

August 13th, 2017

Gornitzky represents Fortissimo Capital Fund in its acquisition of Tuttnauer Co. Ltd. 

Gornitzky represented Fortissimo Capital Fund in its acquisition of Tuttnauer Co. Ltd. Since 1925, Tuttnauer has been and continues to operate as a leading manufacturer and supplier of autoclaves, washers and other sterilization applications and devices.

 

Fortissimo was represented by Chaim Friedland (Partner, Corporate/M&A), Idan Baki (Partner, Finance), Avner Finkelshtein (Partner, Antitrust), together with associates Yoav Meer, Alon Peled, Nir Knoll and Coral Leshez.

July 11th, 2017

Gornitzky represents Le Peigne in its investment in Riskified Ltd.

Gornitzky represented Le Peigne in its investment in Riskified Ltd., an Israeli startup company specializing in e-commerce fraud prevention, as part of a consortium of investors in Riskified’s USD 33 million financing round. Le Peigne is controlled by the Arnault Group, which also controls Christian Dior and LVMH Moet-Hennessy—Louis Vitton.


Le Peigne was represented by Chaim Friedland (Partner) and Yoav Meer.

April 11th, 2016

Gornitzky & Co. is representing AHAVA shareholders in connection with the sale of 100% of AHAVA's shares to Fosun Group for an aggregate price of NIS 290 million

Gornitzky represented the shareholders of AHAVA - Dead Sea Laboratories Ltd., a manufacturer of cosmetic products composed of mineral-rich mud from the Dead Sea. Its products are sold in over 25 different countries. Gornitzky advised the shareholders in connection with the sale of 100% of the shares to the large Chinese investment conglomerate, Fosun Group, for an aggregate price of NIS 290 million. Within the framework of the agreement, Fosun will purchase the share capital of all of AHAVA’s shareholders, Gaon Holdings, the Livnat family, Shamrock Israel Growth Fund, Kibbutz Mitzpeh Shalem and Kibbutz Kalia.

 

See related article in Globes, one of Israel’s leading financial daily newspapers.

 

The shareholders were represented by Chaim Friedland (Partner, Corporate/M&A), Yoav Meer  (Corporate), Nir Knoll (Corporate), Danielle Skald (Tax), Bar Sarafian (Employment)

July 1st, 2015

Gornitzky represented Milchan Media Ltd. in the sale of a portion of its shares in Israel's Channel 10 to the R.G.E Group Ltd.

 

Gornitzky represented Milchan Media Ltd. in the sale of a portion of its shares in Israel's Channel 10 to the R.G.E Group Ltd. Channel 10, one of only three privately-owned broadcasting channels in Israel. The channel has recently been granted a 15-year broadcasting license, making Channel 10 the first of the three to obtain such license. 

 

Milchan Media is ultimately owned by Mr. Arnon Milchan, a well-known international film producer who has produced over 130 full-length motion pictures (including Pretty Woman, 12 Years a Slave, Gone Girl, L.A. Confidential, Fight Club, and Mr. and Mrs. Smith).

 

Milchan Media Ltd. was represented by Lior Porat (Partner) and Yoav Meer.

March 25th, 2015

Gornitzky & Co. represented the underwriters, led by Wells Fargo and RBC, in the USD 40 million initial public offering of SteadyMed Ltd. on the NASDAQ Global Market. 

Gornitzky & Co. represented the underwriters, led by Wells Fargo and RBC, in the USD 40 million initial public offering of SteadyMed Ltd. on the NASDAQ Global Market. SteadyMed is a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value diseases with unmet parenteral delivery needs.

Wells Fargo Securities and RBC Capital Markets acted as joint book-running managers for the offering. JMP Securities acted as lead manager for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

January 15th, 2015

Gornitzky represented Le Peigne in its investment in Moovit, as part of a consortium of investors in Moovit’s USD 50 million financing round. 

Gornitzky represented Le Peigne in its investment in Moovit, as part of a consortium of investors in Moovit’s USD 50 million financing round. Le Peigne is controlled by the Arnault Group, which also controls Christian Dior and LVMH Moet-Hennessy—Louis Vitton. 

 

Moovit is a mobile application that enables users to track information on public transport. 

 

Le Peigne was represented by Chaim Friedland (Partner) and Yoav Meer.

October 6th, 2014

Gornitzky represented the underwriters, led by Deutsche Bank, in the USD 40 million initial public offering of Vascular Biogenics Ltd. (operating as VBL Therapeutics) on the NASDAQ Global Market.

Gornitzky represented the underwriters, led by Deutsche Bank, in the USD 40 million initial public offering of Vascular Biogenics Ltd. (operating as VBL Therapeutics) on the NASDAQ Global Market.

 

Deutsche Bank acted as book-running manager for the offering. JMP Securities and Oppenheimer & Co. acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

April 1st, 2014

Gornitzky represented Strauss Investments (1993) Ltd. in a change of shareholders composition in Reshet-Noga Ltd., the Israeli Channel 2 concessioner. 

Gornitzky represented Strauss Investments (1993) Ltd. in a change of shareholders composition in Reshet-Noga Ltd., the Israeli Channel 2 concessioner, and the entrance of a new major shareholder – Endemol Group.

 

Strauss Investments (1993) Ltd. was represented by Lior Porat (Partner), Avner Finkelstein (Partner, Antitrust) and Yoav Meer.

March 5th, 2014

Gornitzky & Co. represented the underwriters, led by Bank of America Merrill Lynch and Jefferies, in the USD 151 million secondary public offering of shares of Enzymotec Ltd. on the NASDAQ Global Select Market.


Gornitzky & Co. represented the underwriters, led by Bank of America Merrill Lynch and Jefferies, in the USD 151 million secondary public offering of shares of Enzymotec Ltd. on the NASDAQ Global Select Market.

 

Bank of America Merrill Lynch and Jefferies acted as joint book-running managers for the offering. Wells Fargo Securities acted as lead manager for the offering and Canaccord Genuity and Wedbush Securities acted as co-managers for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

October 3rd, 2013

Gornitzky & Co. represented the underwriters, led by Bank of America Merrill Lynch and Jefferies, in the USD 71 million initial public offering of Enzymotec Ltd. on the NASDAQ Global Select Market.

Gornitzky & Co. represented the underwriters, led by Bank of America Merrill Lynch and Jefferies, in the USD 71 million initial public offering of Enzymotec Ltd. on the NASDAQ Global Select Market.

 

Bank of America Merrill Lynch and Jefferies LLC acted as joint book-running managers for the offering. Wells Fargo Securities, LLC acted as lead manager for the offering and Canaccord Genuity and Wedbush Securities acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Yoav Meer.

May 8th, 2013

Gornitzky represented an international consortium of investors in the acquisition of a controlling stake in Carmel Winery, valued at NIS 130 million.

Gornitzky represented an international consortium of investors in the acquisition of a controlling stake in Carmel Winery. The winery, valued at NIS 130 million, is Israel’s oldest and largest commercial winery, founded in 1882 by Baron Edmond de Rothschild.

 

The purchasing consortium was organized by Kedma Capital, a private equity fund, and is comprised of both Israeli and foreign investors, including the Jesselson family.

The investors were represented by Chaim Friedland (Partner), Yisrael Spero (Partner), Avner Finkelshtein and Yoav Meer.

February 14th, 2013

Gornitzky represented Rutledge Vine Capital in its equity investment in Tok Media International Ltd., a private company in the social media space.

Gornitzky represented Rutledge Vine Capital in its equity investment in Tok Media International Ltd., a private company in the social media space. Rutledge's investment in Tok Media marks its fourth investment in Israel represented by Gornitzky.


Rutledge Vine Capital is a global Super Angel Investor that provides early stage venture funding to startup & seed companies and technovation research projects across the world.


Rutledge was represented by Mr. Ari Fried (Partner) and Mr. Yoav Meer.

December 17th, 2012

Recently, Gornitzky & Co. welcomed two new partners to its ranks, Mr. Harel Shaham and Mr. Yisrael Spero. Also to join the firm, are seven new associates.

Recently, Gornitzky & Co. welcomed two new partners to its ranks, Mr. Harel Shaham and Mr. Yisrael Spero. Also to join the firm, are seven new associates.

 

Mr. Shaham has been an associate with the firm since 2006 and specializes in complex civil and commercial litigation cases, including in the fields of capital markets, shareholder disputes, real estate, tenders, insurance, slander, administrative law and labor law, as well as in class actions and derivative suits.

 

Mr. Spero has been an associate with the firm since 2007 and focuses his legal practice on domestic and cross border M&A transactions, private equity investments and complex commercial transactions.


Gornitzky & Co. has also welcomed seven new associates to its ranks, including Ms. Joanna Yanowsky, who was previously an associate at a leading, boutique labor law firm, and Ms. Shirin Gabbay-Metzger, Ms. Elinor Vardi, Ms. Noga Haruvi, Ms. Bat-Hen Mazor, Mr. Yoav Meer and Mr. Ram Shchory, who have recently completed their legal clerkship at the firm.